You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adenoviridae Infections

Showing 1 - 25 of 7,098
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cytomegalovirus, Adenovirus Trial in Memphis (VST infusion, CliniMACS)

Not yet recruiting
  • Cytomegalovirus
  • Adenovirus
  • VST infusion
  • CliniMACS
  • Memphis, Tennessee
    St . Jude Children's Research Hospital
Jan 9, 2023

Adenovirus Infection Trial in Columbus (Adenovirus Specific T lymphocytes)

Recruiting
  • Adenovirus Infection
  • Adenovirus Specific T lymphocytes
  • Columbus, Ohio
    Nationwide Children's Hospital
Sep 1, 2022

Malignant Melanomas Trial in Fuzhou (Recombinant Human Adenovirus Type 5 Injection)

Enrolling by invitation
  • Malignant Melanomas
  • Recombinant Human Adenovirus Type 5 Injection
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital, Department of Internal Medicine, Ward 19
Jul 7, 2023

Adenovirus Infections in Allogenic Hematopoietic Cell Transplant

Completed
  • Adenovirus Infections, Human
    • (no location specified)
    Mar 10, 2022

    Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in

    Recruiting
    • Malignant Pleural Mesothelioma, Advanced
    • Oncolytic Adenovirus H101
    • Programmed death receptor-1 inhibitor
    • Tianjin, Tianjin, China
      Tianjin Medical Unversity Second Hospital
    Sep 2, 2023

    Adenovirus Infection, BK Virus Infection, Cytomegaloviral Infection Trial in Houston (Virus-specific Cytotoxic T-lymphocytes)

    Recruiting
    • Adenovirus Infection
    • +6 more
    • Virus-specific Cytotoxic T-lymphocytes
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 6, 2023

    Bladder Cancer Trial in Hangzhou (H101, Camrelizumab)

    Recruiting
    • Bladder Cancer
    • H101, Camrelizumab
    • Hangzhou, Zhejiang, China
      Hua Wang
    Oct 2, 2022

    Malignant Melanoma, Liver Metastases Trial (Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel)

    Not yet recruiting
    • Malignant Melanoma
    • Liver Metastases
    • Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel
    • (no location specified)
    Dec 23, 2022

    Adenovirus Infection, EBV, Cytomegalovirus Infections Trial in Basel (IFN-? positive selected T-cells)

    Recruiting
    • Adenovirus Infection
    • +4 more
    • IFN-γ positive selected T-cells
    • Basel, Switzerland
      Universitätsspital Basel
    Apr 11, 2022

    Adenovirus Type-5 Vectored COVID-19 Vaccine Trial in Wuhan (Adenovirus Type-5 Vectored COVID-19 Vaccine)

    Completed
    • Adenovirus Type-5 Vectored COVID-19 Vaccine
    • Adenovirus Type-5 Vectored COVID-19 Vaccine
    • Wuhan, Hubei, China
      A rehabilitation centre in Wuhan
    Mar 28, 2022

    Platinum-refractory Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial in Rochester, Helsinki (TILT-123, Pembrolizumab)

    Recruiting
    • Platinum-refractory Ovarian Carcinoma
    • Platinum-resistant Ovarian Cancer
    • TILT-123
    • Pembrolizumab
    • Rochester, Minnesota
    • +1 more
    Aug 12, 2022

    Epstein-Barr Virus Infections, Adenovirus, Cytomegalovirus Infections Trial in Milwaukee (Cytotoxic T Lymphocytes)

    Completed
    • Epstein-Barr Virus Infections
    • +2 more
    • Cytotoxic T Lymphocytes
    • Milwaukee, Wisconsin
      Medical College of Wisconsin
    Oct 21, 2021

    Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential Immunization Trial

    Recruiting
    • Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential Immunization
    • Recombinant adenovirus type-5-vectored COVID-19 vaccine
    • Hangzhou, Zhejiang, China
      Xihu District Center for Disease Control and Prevention
    May 12, 2022

    Advanced/Metastatic Solid Tumours Trial in Canada (MG1MA3, AdMA3)

    Active, not recruiting
    • Advanced/Metastatic Solid Tumours
    • MG1MA3
    • AdMA3
    • Vancouver, British Columbia, Canada
    • +3 more
    Jan 30, 2023

    Solid Tumor Trial in Helsinki (TILT-123)

    Recruiting
    • Solid Tumor
    • TILT-123
    • Helsinki, Uusima, Finland
    • +1 more
    Dec 17, 2021

    Head Neck Cancer, Melanoma, Breast Cancer Trial in Shanghai (Recombinant L-IFN adenovirus injection)

    Recruiting
    • Head and Neck Cancer
    • +6 more
    • Recombinant L-IFN adenovirus injection
    • Shanghai, Shanghai, China
      Shanghai Fengxian District Central Hospital
    Jan 16, 2022

    Tuberculosis Trial in Hamilton (Ad5Ag85A)

    Completed
    • Tuberculosis
    • Ad5Ag85A
    • Hamilton, Ontario, Canada
      McMaster University Medical Centre
    Oct 25, 2021

    Adenovirus Infection Trial in United States (BCV)

    Recruiting
    • Adenovirus Infection
    • Los Angeles, California
    • +10 more
    May 24, 2022

    Adenovirus, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)

    Recruiting
    • Adenovirus
    • Primary Immune Deficiency Disorder
    • cytotoxic t-lymphocytes
    • Los Angeles, California
    • +8 more
    Sep 27, 2022

    HIV Trial in United States (MRKAd5 HIV-1 gag/pol/nef)

    Completed
    • HIV Infections
    • MRKAd5 HIV-1 gag/pol/nef
    • Birmingham, Alabama
    • +3 more
    Oct 13, 2021

    Covid19 Trial in Caba, Capital Federal (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV))

    Recruiting
    • Covid19
    • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV)
    • Caba, Buenos Aires, Argentina
    • +3 more
    Sep 14, 2021

    Pancreas Cancer Trial in Seongnam (Theragene arm)

    Recruiting
    • Pancreas Cancer
    • Theragene arm
    • Seongnam, Gyeonggi-do, Korea, Republic of
      Seoul National University Bundang Hospital
    Mar 15, 2021

    Adenovirus Trial in Italy, Spain, United States (Brincidofovir, Standard of Care)

    Withdrawn
    • Adenovirus
    • Los Angeles, California
    • +7 more
    Jul 19, 2021

    Cytomegalovirus Infections, Adenovirus Infection, EBV Infection Trial in United States (Virus Specific T-cell (VST) infusion)

    Active, not recruiting
    • Cytomegalovirus Infections
    • +2 more
    • Virus Specific T-cell (VST) infusion
    • Phoenix, Arizona
    • +29 more
    Mar 2, 2022

    Adenovirus Keratoconjunctivitis and Ophtalmology

    Recruiting
    • Adenoviral Keratoconjunctivitis
      • Clermont-Ferrand, France
        University hospital, Clermont-Ferrand
      Jun 3, 2020